The Epigenetic Theory of Carcinogenesis: p53 as the Guardian of The Epigenome

Journal Title: Journal of Oncology and Cancer Research - Year 2017, Vol 1, Issue 1

Abstract

The principal advantage of the hypothesis that the multiple phenotypic abnormalities characteristic of malignant and pre-malignant cells result from epigenetic disorder is that it accounts for the wide spectrum of anomalies exhibited by these cells without recourse to postulating a raised mutation rate. The basic proposal is that derangement of the process of copying the epigenetic pattern during proliferation of differentiated stem cells enables dysregulated genetic re-programming and de-differentiation of the affected progeny, a phenomenon that might be termed “epimutation”. This results in the generation of abnormal clones expressing divergent structural and functional characteristics, some of which embue the cells with malignant properties. The epigenetic theory of carcinogenesis postulates that the initiating mutations cause deranged vertical transmission of the epigenetic pattern established in proliferating differentiated stem cells. The failure of fidelity of copying the epigenetic pattern results in changes of expression of genes, including the re-expression of previously silenced genes characteristic of earlier developmental stages or of other tissues. The mechanism involves the generation of chromosomal abnormalities and deranged cellular organization. Some clones acquire properties that render them capable of transgressing tissue boundaries and proliferating in distant sites, i.e. they exhibit malignant behavior. The mathematical features of the theory are concomitant with established accounts of age-specific incidence of adult human malignancies and the proposed mechanism accounts for the known characteristics of cancer.

Authors and Affiliations

Patrick A Riley

Keywords

Related Articles

Hedgehog Inhibitors are Effective Treatment for Basal Cell Cancer Recurrence

The hedgehog signaling pathway is one of the major regulators of cell growth and differentiation during embryogenesis. Mutation of some component of hedgehog pathway is common in cancers, especially in basal cell carcino...

Effect of Radiotherapy on Antioxidant Vitamin E in Patients with Carcinoma Uterine Cervix- a Pilot Study

Vitamin E, a fat-soluble antioxidant, stops the production of Reactive Oxygen Species (ROS) during the process of fat oxidation. It is used to prevent and repair normal tissue damage and to increase the susceptibility of...

The Epigenetic Theory of Carcinogenesis: p53 as the Guardian of The Epigenome

The principal advantage of the hypothesis that the multiple phenotypic abnormalities characteristic of malignant and pre-malignant cells result from epigenetic disorder is that it accounts for the wide spectrum of anomal...

Objectively Recorded Physical Activity And Perceived Distress At The Beginning Of Oncological Treatment

Purpose: To examine the association between physical activity (PA), objectively recorded as number of steps and hours of moderate- to- vigorous intensity PA, and self- reported distress (anxiety, depression, intrusion an...

Have Cluster Randomised Trials a Role in Health Care Research?

Cluster Randomised trials, where groups of individuals are randomised to different treatments and outcomes measured on individuals, have many limitations inherent in the trial design. Selection bias can be introduced int...

Download PDF file
  • EP ID EP249309
  • DOI 10.28967/jocr.2017.01.17002
  • Views 110
  • Downloads 0

How To Cite

Patrick A Riley (2017). The Epigenetic Theory of Carcinogenesis: p53 as the Guardian of The Epigenome. Journal of Oncology and Cancer Research, 1(1), 8-13. https://europub.co.uk/articles/-A-249309